These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies. Arimori T; Mihara E; Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Takagi J; Kato Y Structure; 2024 May; 32(5):536-549.e5. PubMed ID: 38460519 [TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model. Matsui Y; Inomata M; Tojigamori M; Sonoda K; Shiraishi N; Kitano S Int J Oncol; 2005 Sep; 27(3):681-5. PubMed ID: 16077916 [TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody. Huang S; Li F; Liu H; Ye P; Fan X; Yuan X; Wu Z; Chen J; Jin C; Shen B; Feng J; Zhang B MAbs; 2018; 10(6):864-875. PubMed ID: 30081724 [TBL] [Abstract][Full Text] [Related]
19. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging. Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859 [TBL] [Abstract][Full Text] [Related]